Safety, Efficacy, and Tolerability of NBI-827104 for the Treatment of Essential Tremor
Clinical trial NCT04880616 · COMPLETED
Trial details
- NCT number
- NCT04880616
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-20
- Primary completion
- 2022-05-25
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.